Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Sodium Gualenate [INN]
RN: 6223-35-4
UNII: 19WSH095WP
InChIKey: GEYJUFBPCGDENK-UHFFFAOYSA-M

Classification Code

  • Drug / Therapeutic Agent

Molecular Formulas

  • C15-H17-Na-O3-S
  • C15-H18-O3-S.Na

Molecular Weight

  • 300.3523
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • 1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt
  • 3,8-Dimethyl-5-(1-methylethyl)-1-azulenesulfonic acid, sodium salt
  • Guaiazulene 3-sulfonate sodium salt
  • Sodium 3,8-dimethyl-5-(1-methylethyl)-1-azulenesulfonate
  • Sodium Gualenate [INN]
  • Sodium guiazulene sulfonate

Synonyms

  • 3,8-Dimethyl-5-(1-methylethyl)-1-azulenesulfonic acid sodium salt
  • Azulen SN
  • Azulene sulfonate sodium
  • Azulon
  • Azupromin
  • CCRIS 3781
  • EINECS 228-309-8
  • Guajazulen-3-sulfonsaeure, natriumsalz
  • Gualenate de sodium
  • Gualenate de sodium [INN-French]
  • Gualenato sodico
  • Gualenato sodico [INN-Spanish]
  • Gualenato sodidico
  • Natrii gualenas
  • Natrii gualenas [INN-Latin]
  • Natrium 7-isopropyl-1,4-dimethyl-3-azulensulfonat
  • Sodium 5-isopropyl-3,8-dimethyl-1-azulene sulfonate
  • Sodium 7-isopropyl-1,4-dimethylazulene-3-sulfonate
  • Sodium guaiazulene-3-sulfonate
  • Sodium gualenate
  • UNII-19WSH095WP

Systematic Names

  • 1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt (9CI)
  • 1-Azulenesulfonic acid, 5-isopropyl-3,8-dimethyl-, sodium salt
  • Azuletil sodium
  • Sodium 5-isopropyl-3,8-dimethyl-1-azulene sulfonate
  • Sodium gualenate

Registry Numbers

CAS Registry Number

  • 6223-35-4

FDA UNII

  • 19WSH095WP

Other Registry Number

  • 133414-61-6

System Generated Number

  • 0006223354

Molecular Formulas

Molecular Formulas

  • C15-H17-Na-O3-S
  • C15-H18-O3-S.Na

Molecular Formula Fragments

  • C15-H18-O3-S
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/C15H18O3S.Na/c1-9(2)12-6-5-10(3)15-13(8-12)11(4)7-14(15)19(16,17)18;/h5-9H,1-4H3,(H,16,17,18);/q;+1/p-1

InChIKey

GEYJUFBPCGDENK-UHFFFAOYSA-M

Smiles

c12c(c(cc1S(=O)(=O)[O-])C)cc(ccc2C)C(C)C.[Na+]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 105mg/kg (105mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA
Shinryo to Shinyaku. Medical Consultation and New Remedies. Vol. 11, Pg. 2533, 1974.
mouse LD50 oral 1540mg/kg (1540mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 615, 1969.
mouse LD50 subcutaneous 145mg/kg (145mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Shinryo to Shinyaku. Medical Consultation and New Remedies. Vol. 11, Pg. 2533, 1974.
rat LD50 intraperitoneal 180mg/kg (180mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Shinryo to Shinyaku. Medical Consultation and New Remedies. Vol. 11, Pg. 2533, 1974.
rat LD50 oral 6380mg/kg (6380mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 615, 1969.
rat LD50 subcutaneous 520mg/kg (520mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Shinryo to Shinyaku. Medical Consultation and New Remedies. Vol. 11, Pg. 2533, 1974.